603718 海利生物
按盤價 
6.600 +0.020 (+0.304%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.620 | 5.334 | 11.334 | 5.219 | 0.840 |
| 總資產報酬率 ROA (%) | 1.230 | 3.964 | 7.242 | 2.967 | 0.512 |
| 投入資產回報率 ROIC (%) | 1.532 | 5.051 | 10.793 | 5.012 | 0.787 | 邊際利潤分析 |
| 銷售毛利率 (%) | 49.080 | 51.394 | 58.969 | 55.767 | 46.837 |
| 營業利潤率 (%) | -15.716 | 22.919 | 23.309 | 16.482 | -8.339 |
| 息稅前利潤/營業總收入 (%) | 6.146 | 24.417 | 46.493 | 19.928 | -2.716 |
| 淨利潤/營業總收入 (%) | 8.834 | 20.776 | 36.898 | 13.149 | -12.408 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | -490.379 | -12.366 | 6.497 | 34.243 | 192.621 |
| 價值變動淨收益/利潤總額(%) | 93.813 | 101.072 | 8.615 | 62.819 | -107.484 |
| 營業外收支淨額/利潤總額(%) | 476.697 | 1.521 | 46.711 | -0.179 | 7.428 | 償債能力分析 |
| 流動比率 (X) | 3.153 | 1.349 | 2.073 | 1.456 | 1.160 |
| 速動比率 (X) | 2.924 | 1.102 | 1.622 | 1.243 | 0.979 |
| 資產負債率 (%) | 24.514 | 29.133 | 26.630 | 46.467 | 46.148 |
| 帶息債務/全部投入資本 (%) | 3.246 | 0.619 | -2.041 | -13.039 | -- |
| 股東權益/帶息債務 (%) | 2,919.130 | 15,234.977 | -4,661.548 | -731.025 | -711.071 |
| 股東權益/負債合計 (%) | 319.778 | 251.985 | 282.786 | 117.354 | 128.353 |
| 利息保障倍數 (X) | 3.113 | 21.344 | 16.889 | 5.735 | -0.432 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 135.559 | 136.280 | 112.325 | 77.648 | 0.000 |
| 存貨周轉天數 (天) | 285.161 | 381.076 | 420.438 | 302.978 | 0.000 |
| 備註： | 即時報價更新時間為 17/01/2025 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
